tiprankstipranks
Advertisement
Advertisement

XTNT Stock Latest News

Xtant Medical initiated with a Buy at Lucid Capital
The FlyXtant Medical initiated with a Buy at Lucid Capital
11d ago
XTNT
Analyst Reiterates Buy on Xtant, Citing BioHorizons Partnership and High-Margin OsteoFactor Pro as Key Growth Drivers
PremiumRatings
Analyst Reiterates Buy on Xtant, Citing BioHorizons Partnership and High-Margin OsteoFactor Pro as Key Growth Drivers
16d ago
XTNT
Xtant Medical announces exclusive partnership with BioHorizons
PremiumThe Fly
Xtant Medical announces exclusive partnership with BioHorizons
17d ago
XTNT
Xtant Medical Earnings Call: Growth Bets Amid Setbacks
PremiumCompany Announcements
Xtant Medical Earnings Call: Growth Bets Amid Setbacks
20d ago
XTNT
Xtant Medical lowers 2026 revenue view to $99M-$103M from $101M-$105M
PremiumThe Fly
Xtant Medical lowers 2026 revenue view to $99M-$103M from $101M-$105M
1M ago
XTNT
Xtant Medical Stockholders Approve Governance and Leadership Items
PremiumCompany AnnouncementsXtant Medical Stockholders Approve Governance and Leadership Items
1M ago
8K
XTNT
Xtant Medical Balances New Growth Bets With Near-Term Pain
Premium
Company Announcements
Xtant Medical Balances New Growth Bets With Near-Term Pain
4M ago
XTNT
Xtant Medical’s HEMOBLAST Deal with Dilon: High Sales Spend, Single‑Supplier Dependence and Termination Risk Threaten Returns
Premium
Company Announcements
Xtant Medical’s HEMOBLAST Deal with Dilon: High Sales Spend, Single‑Supplier Dependence and Termination Risk Threaten Returns
4M ago
XTNT
Xtant Medical Boosts 2026 Outlook Amid Tough Quarter
PremiumCompany Announcements
Xtant Medical Boosts 2026 Outlook Amid Tough Quarter
4M ago
XTNT
Xtant Medical reports Q1 EPS (2c) vs. 0c last year
PremiumThe Fly
Xtant Medical reports Q1 EPS (2c) vs. 0c last year
4M ago
XTNT
Xtant Medical raises FY26 revenue view to $101M-$105M from $95M-$99M
PremiumThe Fly
Xtant Medical raises FY26 revenue view to $101M-$105M from $95M-$99M
4M ago
XTNT
Xtant Medical Updates Q1 Results and Raises 2026 Guidance
PremiumCompany Announcements
Xtant Medical Updates Q1 Results and Raises 2026 Guidance
4M ago
8K
XTNT
Xtant Medical resumed with a Buy at Maxim
PremiumThe FlyXtant Medical resumed with a Buy at Maxim
5M ago
XTNT
Xtant Medical Expands Portfolio with HEMOBLAST Distribution Deal
Premium
Company Announcements
Xtant Medical Expands Portfolio with HEMOBLAST Distribution Deal
5M ago
8K
XTNT
Xtant Medical acquires U.S. distribution rights to Dilon’s Hemoblast Bellows
Premium
The Fly
Xtant Medical acquires U.S. distribution rights to Dilon’s Hemoblast Bellows
5M ago
XTNT
Xtant Medical Warns of 2026 Profit Hit as One‑Time License Revenue and SimpliMax™ Reimbursements Fade
PremiumCompany Announcements
Xtant Medical Warns of 2026 Profit Hit as One‑Time License Revenue and SimpliMax™ Reimbursements Fade
6M ago
XTNT
Xtant Medical Earnings Call Highlights Profitability Turnaround
PremiumCompany Announcements
Xtant Medical Earnings Call Highlights Profitability Turnaround
6M ago
XTNT
Xtant Medical reports Q4 EPS 0c vs. (2c) last year
PremiumThe Fly
Xtant Medical reports Q4 EPS 0c vs. (2c) last year
6M ago
XTNT
Xtant Medical sees 2026 revenue $95M-$99M, consensus $110.1M
PremiumThe Fly
Xtant Medical sees 2026 revenue $95M-$99M, consensus $110.1M
6M ago
XTNT
XTNT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsXTNT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago
XTNT
Xtant Medical Boosts Liquidity After Companion Spine Repayment
Premium
Company Announcements
Xtant Medical Boosts Liquidity After Companion Spine Repayment
6M ago
8K
XTNT
Xtant Medical says transactions with Companion Spine now finalized
Premium
The Fly
Xtant Medical says transactions with Companion Spine now finalized
6M ago
XTNT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >